Nanalysis Announces $2.5 Million Private Placement

Executive Summary

• Nanalysis Scientific Corp. announced a non‑brokered private placement of up to 16,666,667 units at $0.15 per unit, targeting gross proceeds of up to $2.5 million.
• Net proceeds will be used primarily for debt reduction, strengthening the company’s balance sheet.
• Each unit consists of one common share and half a warrant (exercise price $0.20), with acceleration provisions if the TSX‑V share price reaches $0.30 for ten consecutive trading days.

Key Details

• Units Offered: Up to 16,666,667 units at $0.15 per unit.
• Gross Proceeds Target: $2,500,000; net proceeds earmarked for debt repayment.
• Unit Composition:
• 1 common share (“Share”).
• ½ of one common share purchase warrant (“Warrant”).
• Warrant Terms:
• Exercise price $0.20 per Share.
• Valid until two years after the closing date, exercisable any time before 4:00 p.m. Calgary time on that date.
• Acceleration clause: if TSX‑V share price ≥ $0.30 for ten consecutive days, Company may accelerate expiry to 30 days after notice. Unexercised warrants then expire without compensation.
• Closing Timeline: Offering may close in one or more tranches; initial closing expected on or about December 15, 2025.
• Regulatory Conditions: Subject to TSX‑V acceptance and customary closing conditions; securities subject to a statutory hold period of four months and one day.
• Use of Proceeds: Primarily for debt reduction (non‑material impact on operations but improves financial position).

Notable Quotes

(No executive quotes were provided in the release.)